Immatics (IMTX) Change in Account Payables (2020 - 2022)
Immatics (IMTX) posted Change in Account Payables of $69.7 million for Q2 2022, up 89.22% sequentially from $36.8 million in Q1 2022, and up 1325.95% YoY from $4.9 million in Q2 2021.
Immatics (IMTX) Change in Account Payables (2020 - 2022) Analysis & Trends
Immatics has reported Change in Account Payables for 3 years, with the latest figure at $69.7 million in Q2 2022.
- Quarterly Change in Account Payables rose 1325.95% year-over-year to $69.7 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $83.0 million (up 377.8% YoY) and the FY2021 annual result came in at -$37.6 million, down 40.86% from the prior year.
- Change in Account Payables advanced to $69.7 million in Q2 2022 per IMTX's latest filing, from $36.8 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $69.7 million in Q2 2022 and troughed at -$20.1 million in Q4 2021.
- A 3-year average of $4.2 million and a median of -$5.4 million in 2020 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2021 and 2022: Change in Account Payables plunged 82.9% in 2021, then jumped 1325.95% in 2022.
- Over 3 years, Change in Account Payables stood at -$11.0 million in 2020, then slumped by 82.9% to -$20.1 million in 2021, then soared by 446.93% to $69.7 million in 2022.
- According to Business Quant data, Change in Account Payables over the past three periods registered $69.7 million, $36.8 million, and -$20.1 million for Q2 2022, Q1 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 69.66 Mn |
| Jun 30, 2022 | 69.66 Mn |
| Mar 31, 2022 | 36.81 Mn |
| Mar 31, 2022 | 36.81 Mn |
| Dec 31, 2021 | -20.08 Mn |
| Dec 31, 2021 | -20.08 Mn |
| Sep 30, 2021 | -3.38 Mn |
| Sep 30, 2021 | -3.38 Mn |
| Jun 30, 2021 | -5.68 Mn |
| Jun 30, 2021 | -5.68 Mn |
| Mar 31, 2021 | -8.02 Mn |
| Mar 31, 2021 | -8.02 Mn |
| Dec 31, 2020 | -10.98 Mn |
| Dec 31, 2020 | -10.98 Mn |
| Sep 30, 2020 | -5.20 Mn |
| Sep 30, 2020 | -5.20 Mn |
| Jun 30, 2020 | -6.32 Mn |
| Jun 30, 2020 | -6.32 Mn |
| Mar 31, 2020 | -4.40 Mn |
| Mar 31, 2020 | -4.40 Mn |